Latest news
Two Years of Lenalidomide Maintenance Matches Indefinite Therapy in Standard-Risk Myeloma - Pharmacy Practice NewsPharmacy Practice News · Sun, 09 Aug 2026 04:31:50 GMTRethinking Myeloma Lenalidomide Maintenance - Oncology Nursing NewsOncology Nursing News · Fri, 07 Aug 2026 13:10:33 GMTCompounding Panel Backs Peptides for the 503A Bulks List, Against FDA Reviewers’ Recommendations - Pharmacy Practice NewsPharmacy Practice News · Mon, 27 Jul 2026 13:43:55 GMT